The search result changed since you submitted your search request. Documents might be displayed in a different sort order.
  • search hit 4 of 5
Back to Result List

Identification and validation of a novel biologics target in triple negative breast cancer

  • The goal of this study was to identify a novel target for antibody-drug conjugate (ADC) development in triple negative breast cancer (TNBC), which has limited treatment options, using gene expression datasets and in vitro siRNA/CRISPR and in vivo functional assays. We analyzed 4467 breast cancers and identified GABRP as top expressed gene in TNBC with low expression in most normal tissues. GABRP protein was localized to cell membrane with broad range of receptors/cell (815–53,714) and expressed by nearly half of breast cancers tissues. GABRP gene knockdown inhibited TNBC cell growth and colony formation in vitro and growth of MDA-MB-468 xenografts in nude mice. Commercially available anti-GABRP antibody (5–100 μg/ml) or de novo generated Fabs (20 μg/ml) inhibited TNBC cell growth in vitro. The same antibody conjugated to mertansine (DM1) also showed significant anticancer activity at nanomolar concentrations. Our results indicate that GABRP is a potential novel therapeutic target for ADC development.
Metadaten
Author:Vikram B. Wali, Gauri A. Patwardhan, Vasiliki Pelekanou, Thomas Karn, Jian Cao, Alberto Ocana, Qin Yan, Bryce Nelson, Christos Hatzis, Lajos Pusztai
URN:urn:nbn:de:hebis:30:3-551039
DOI:https://doi.org/10.1038/s41598-019-51453-w
ISSN:2045-2322
Pubmed Id:https://pubmed.ncbi.nlm.nih.gov/31624295
Parent Title (English):Scientific reports
Publisher:Macmillan Publishers Limited, part of Springer Nature
Place of publication:[London]
Document Type:Article
Language:English
Year of Completion:2019
Date of first Publication:2019/10/17
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Release Date:2020/07/15
Tag:Breast cancer; Target identification
Volume:9
Issue:1, Art. 14934
Page Number:10
First Page:1
Last Page:10
Note:
Open Access: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
HeBIS-PPN:467792291
Institutes:Medizin / Medizin
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Licence (German):License LogoCreative Commons - Namensnennung 4.0